sensotrend pitch for seedforum

16
AUTOMATED DIABETES DIARY Visualizing data from wellness trackers and medical devices for personalized diabetes treatment

Upload: mikael-rinnetmaeki

Post on 23-Aug-2014

236 views

Category:

Healthcare


11 download

DESCRIPTION

Presenting Sensotrend in SeedForum pitch event. Some progress from the working copy (http://www.slideshare.net/mikaelrinnetmaki/sensotrend-pitch-for-seedforum-draft). Strictest enforcement of the pitch structure that we've experienced so far. Feedback from audience indicated this is both good (easier to compare startups) and bad (gets boring quite soon).

TRANSCRIPT

Page 1: Sensotrend Pitch for SeedForum

AUTOMATED DIABETES DIARY

Visualizing data fromwellness trackers and medical devicesfor personalized diabetes treatment

Page 2: Sensotrend Pitch for SeedForum

TRACKAND

LEARN

Page 3: Sensotrend Pitch for SeedForum

Diabetes treatment costs in 2013: $ 548 B

$

†<60y

Page 4: Sensotrend Pitch for SeedForum

> 1 000 apps, only 1.2 % penetration

“Apps rely on manual input of data.”“No interoperability with glucometers, health & fitness apps.”

Page 5: Sensotrend Pitch for SeedForum

Glucose readings from meter & pumpActivity, nutrition info from trackersAnnotations

Support for multiple metersPatient owns the data

Competition

Page 6: Sensotrend Pitch for SeedForum

PHR

Meals ActivityStress

Page 7: Sensotrend Pitch for SeedForum

Business model: Phase 1

Go-to-market via• Diabetes organizations• Healthcare organizations• App stores

People with diabetes pay 79 € / y

Page 8: Sensotrend Pitch for SeedForum

Revenue Streams: Phase 2Healthcare organizations pay for service and data– Patient empowerment saves cost– Personalized healthcare improves results– Legal obligations

Pharma companies pay for data– Valuable for product development

Insurance companies pay for data– Improved risk calculation– Payer role, want to improve treatment

Device manufacturers pay for integration– Better value for users

Page 9: Sensotrend Pitch for SeedForum

H2/13 2014 2015 2016 2017 2018 2019

Personnel 3 3 3 5 8 12 16 20 30 60 75 90

Users 2 2 500 2.5 K 15 K 40 K 70 K 250 K 600 K 1.2 M 2.5 M 6 M

Revenue 0 0 675 K 1.5 M 11.4 M 92 M 484 M

Cost 0 195 K 950 K 1.4 M 16.1 M 52 M 120 M

Ebitda 0 -195 K -275 K 100 K -4.7 M 40 M 364 M

First users,

soft launch

Launch: F

inland

Launch: E

urope

Medical D

evice Cert.

Financials and Roadmap

FDA ap

proval

Launch

: USA

& Canad

a

Page 10: Sensotrend Pitch for SeedForum

Pirjo Ilanne-Parikka, MD, Finnish Diabetes Assoc.Jorma Lahtela, MD, UTA / UKU / TAYSPäivi Hannula, MD, PSHPAntti Virkamäki, MD, CMO, MendorAtte Vadén, MD, Koskiklinikka / MediverkkoJyrki Lähde, MD, Terveystalo

Type 1 diabetic (14 y), software pro (15 y)Startup experience (14 y)

Type 1 diabetic (4 y), software pro (15 y)Military software, visualisation

Healthcare PR, marketing (6 y)Protomo startup coaching

Mikael

Timo

Assi

Advisors

Page 11: Sensotrend Pitch for SeedForum
Page 12: Sensotrend Pitch for SeedForum
Page 13: Sensotrend Pitch for SeedForum

Trade Sale Opportunities

Page 14: Sensotrend Pitch for SeedForum

Investment Opportunity

Looking for 100 000 €, to– finalize product, start user trials in Q2 2014– launch in Finland on World Diabetes Day 14.11.2014– prepare for next round in Q1 2015, for medical device

certification and international growth

Also looking for advice and connections

Page 15: Sensotrend Pitch for SeedForum

…making sense of diabetes trends

Mikael Rinnetmä[email protected]

+358 50 3855511linkedin.com/in/mikaelrinnetmaki

twitter.com/mrinnetmaki

www.sensotrend.com/linkedin.com/company/sensotrendtwitter.com/sensotrendfacebook.com/sensotrend gust.com/c/sensotrend

Page 16: Sensotrend Pitch for SeedForum

Power Pitch

• Sensotrend makes life with diabetes easierwith an automated diabetes diaryutilizing data from wellness trackers.

• Our team consists of diabetics and their relatives, and we’ve got 6 top name diabetes doctors as advisors.

• We have a scalable business model with multiple revenue streams, and a first mover advantage on a globally growing market, driven by changes in legislation.